These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 8562105)

  • 21. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
    Suttorp MJ; Kingma JH; Jessurun ER; Lie-A-Huen L; van Hemel NM; Lie KI
    J Am Coll Cardiol; 1990 Dec; 16(7):1722-7. PubMed ID: 2123909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group.
    Crijns HJ; Gosselink AT; Lie KI
    Cardiovasc Drugs Ther; 1996 May; 10(2):145-52. PubMed ID: 8842506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study.
    Kochiadakis GE; Igoumenidis NE; Parthenakis FI; Chlouverakis GI; Vardas PE
    J Am Coll Cardiol; 1999 Mar; 33(4):966-71. PubMed ID: 10091823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols.
    Boriani G; Biffi M; Capucci A; Botto G; Broffoni T; Ongari M; Trisolino G; Rubino I; Sanguinetti M; Branzi A; Magnani B
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2470-4. PubMed ID: 9825369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study.
    Azpitarte J; Alvarez M; Baún O; García R; Moreno E; Martín F; Tercedor L; Fernández R
    Eur Heart J; 1997 Oct; 18(10):1649-54. PubMed ID: 9347277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.
    Zhang N; Guo JH; Zhang HCh; Li XB; Zhang P; Xn Y
    Int J Clin Pract; 2005 Dec; 59(12):1395-400. PubMed ID: 16351670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
    Balla I; Petrela E; Kondili A
    Anadolu Kardiyol Derg; 2011 Nov; 11(7):600-6. PubMed ID: 21911317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
    Fresco C; Proclemer A; Pavan A; Buia G; Vicentini A; Pavan D; Morgera T
    Clin Cardiol; 1996 May; 19(5):409-12. PubMed ID: 8723601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.
    Bianconi L; Mennuni M; Lukic V; Castro A; Chieffi M; Santini M
    J Am Coll Cardiol; 1996 Sep; 28(3):700-6. PubMed ID: 8772759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination.
    Tai CT; Chen SA; Feng AN; Yu WC; Chen YJ; Chang MS
    Circulation; 1998 May; 97(19):1935-45. PubMed ID: 9609087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
    Roy D; Talajic M; Dorian P; Connolly S; Eisenberg MJ; Green M; Kus T; Lambert J; Dubuc M; Gagné P; Nattel S; Thibault B
    N Engl J Med; 2000 Mar; 342(13):913-20. PubMed ID: 10738049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration.
    Boriani G; Capucci A; Lenzi T; Sanguinetti M; Magnani B
    Chest; 1995 Aug; 108(2):355-8. PubMed ID: 7634866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiodarone -- waxed and waned and waxed again.
    Doggrell SA
    Expert Opin Pharmacother; 2001 Nov; 2(11):1877-90. PubMed ID: 11825323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset.
    Bianconi L; Boccadamo R; Pappalardo A; Gentili C; Pistolese M
    Am J Cardiol; 1989 Aug; 64(5):335-8. PubMed ID: 2667304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
    Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP
    Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study.
    Vardas PE; Kochiadakis GE; Igoumenidis NE; Tsatsakis AM; Simantirakis EN; Chlouverakis GI
    Chest; 2000 Jun; 117(6):1538-45. PubMed ID: 10858380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery.
    Beaulieu Y; Denault AY; Couture P; Roy D; Talajic M; O'Meara E; Carrier M; Pagé P; Levesque S; Lambert J; Tardif JC
    Anesthesiology; 2010 Jan; 112(1):128-37. PubMed ID: 19996947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
    Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.